In The Conversation, Dr. Melissa Armstrong explains LBD, how it's diagnosed and current avenues for researching the disease.
The Institute for Human and Machine Cognition's podcast, STEM-Talk, features Michael Okun, M.D., who talks about the complexity and treatment of Parkinson's disease.
Dr. Todd Golde and colleagues published a review in Nature Neuroscience highlighting the usefulness and limitations of using mouse models to study neurodegenerative diseases.
DBS pioneers Kelly Foote, M.D., and Michael Okun, M.D., co-directors of the Fixel Center for Neurological Diseases at UF Health, shared their expertise at the Cade Museum.
A mouse-model study led by Drs. Paramita Chakrabarty and Todd Golde describes how their team bioengineered a naturally occurring protein to enable it to bind to amyloid beta protein in the brain.
MBI members discuss how the service and science hub specialty care model is working at the Fixel Center.
Melissa Armstrong, M.D., M.Sc., was senior author on a new guideline highlighting the importance of an accurate diagnosis and proper care for those in vegetative and minimally conscious states.
Following Alan Alda’s announcement that he has Parkinson’s, Dr. Michael Okun explains in an article for The Conversation that it’s a livable disease, but there’s a critical shortage of doctors to treat it.
Michael Okun, M.D., neurology chair and medical director of the National Parkinson's Foundation, comments on actor Alan Alda revealing that he was diagnosed with Parkinson's disease three-and-a-half years ago in USA Today and the New York Daily News.